Search Results - "Tassies, Dolors"

Refine Results
  1. 1

    Impact of Continuous Estroprogestin Treatment on Circulating Microparticle Levels in Deep Endometriosis Patients by Carrillo Torres, Pilar, Martínez-Zamora, María Ángeles, Tàssies, Dolors, Castillo, Helena, Gracia, Meritxell, Feixas, Georgina, Reverter, Joan Carles, Carmona, Francisco

    “…There has been increasing interest in the study of new pathogenic mechanisms in endometriosis (END), including the coagulation/fibrinolysis system and its link…”
    Get full text
    Journal Article
  2. 2

    Is antivitamin K reversal required in patients with cirrhosis undergoing liver transplantation? by Martinez, Samira, Garcia, Isabel, Ruiz, Angel, Tàssies, Dolors, Reverter, Joan Carles, Colmenero, Jordi, Beltran, Joan, Fondevila, Constantino, Blasi, Annabel

    Published in Transfusion (Philadelphia, Pa.) (01-10-2021)
    “…Background Antivitamin K agent (AVK) reversal in patients with cirrhosis awaiting liver transplantation (LT) is not defined in guidelines. We investigated the…”
    Get full text
    Journal Article
  3. 3

    Procoagulant microparticles are associated with arterial disease in patients with systemic lupus erythematosus by Plasín-Rodríguez, Miguel Angel, Patricio, Patricia, Monteagudo, Joan, García-Criado, Angeles, Cervera, Ricard, Reverter, Joan Carles, Espinosa, Gerard, Tàssies, Dolors

    Published in Journal of thrombosis and thrombolysis (01-07-2021)
    “…Microparticles (MPs) have been associated with inflammatory and thrombotic disease. High levels of MPs have been identified in patients with systemic lupus…”
    Get full text
    Journal Article
  4. 4

    Long-term follow-up of antiphospholipid syndrome: real-life experience from a single center by Serrano, Rosa, Pons-Estel, Guillermo J, Espinosa, Gerard, Quintana, Rosana M., Reverter, Joan C, Tassies, Dolors, Monteagudo, Joan, Cervera, Ricard

    Published in Lupus (01-08-2020)
    “…Objective The objective of this paper is to assess the prevalence of the main clinical manifestations and laboratory features at disease onset and during the…”
    Get full text
    Journal Article
  5. 5

    The H1 haplotype of the endothelial protein C receptor protects against arterial thrombosis in patients with antiphospholipid syndrome by Plasín-Rodríguez, Miguel Angel, Rodríguez-Pintó, Ignasi, Patricio, Patricia, Monteagudo, Joan, Cervera, Ricard, Reverter, Joan Carles, Espinosa, Gerard, Tàssies, Dolors

    Published in Thrombosis research (01-09-2018)
    “…Genetic variants in the endothelial protein C receptor gene (PROCR) may contribute to the thrombosis risk by regulating levels of the soluble form of this…”
    Get full text
    Journal Article
  6. 6

    ADAMTS-13 in Critically Ill Patients With Septic Syndromes and Noninfectious Systemic Inflammatory Response Syndrome by Aibar, Jesús, Castro, Pedro, Espinosa, Gerard, Fernández, Sara, Hernández, Cristina, Rinaudo, Mariano, Butjosa, Montserrat, Tàssies, Dolors, Reverter, Joan Carles, Nicolás, Josep Maria

    Published in Shock (Augusta, Ga.) (01-06-2015)
    “…ABSTRACTPurposeDecreased ADAMTS-13 (A Disintegrin and Metalloprotease with a ThromboSpondin type 1 motif, member 13) seems to be associated with a poor…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    High Prevalence of Prothrombotic Abnormalities in Multifocal Osteonecrosis: Description of a Series and Review of the Literature by Gómez-Puerta, Jose A., Peris, Pilar, Reverter, Joan Carles, Espinosa, Gerard, Martinez-Ferrer, Angeles, Monegal, Ana, Monteagudo, Juan, Tàssies, Dolors, Guañabens, Nuria

    Published in Medicine (Baltimore) (01-11-2013)
    “…Multifocal or multiple osteonecrosis (ON), defined by the involvement of 3 or more anatomic sites, is unusual, being observed in only 3%-10% of patients…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Increased circulating cell-derived microparticle count is associated with recurrent implantation failure after IVF and embryo transfer by Martinez-zamora, M. Angeles, Tassies, Dolors, Reverter, Juan Carlos, Creus, Montserrat, Casals, Gemma, Civico, Salvadora, Carmona, Francisco, Balasch, Juan

    Published in Reproductive biomedicine online (01-08-2016)
    “…Abstract Cell-derived microparticles (cMPs) are small membrane vesicles that are released from many different cell types in response to cellular activation or…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Solid cancer, antiphospholipid antibodies, and venous thromboembolism by Font, Carme, Vidal, Laura, Espinosa, Gerard, Tàssies, Dolors, Monteagudo, Joan, Farrús, Blanca, Visa, Laura, Cervera, Ricard, Gascon, Pere, Reverter, Joan C

    Published in Autoimmunity reviews (01-02-2011)
    “…Abstract The pathogenic role of antiphospholipid antibodies (aPL) in the development of venous thromboembolism (VTE) in patients with malignancies has not been…”
    Get full text
    Journal Article
  17. 17

    Pregnancy-Associated Plasma Protein-A Levels Are Related to Glycemic Control but Not to Lipid Profile or Hemostatic Parameters in Type 2 Diabetes by Pellitero, Silvia, Reverter, Jordi L, Pizarro, Eduarda, Pastor, Maria Cruz, Granada, Maria Luisa, Tàssies, Dolors, Reverter, Juan-Carlos, Salinas, Isabel, Sanmartí, Anna

    Published in Diabetes care (01-12-2007)
    “…A possible hypothesis to consider is that PAPP-A may not be a good marker of vascular risk in chronic diseases such as diabetes. In fact, PAPP-A would be a…”
    Get full text
    Journal Article
  18. 18

    Increased circulating cell-derived microparticle levels in deep infiltrating endometriosis patients with larger implants by Munrós, Jordina, Tàssies, Dolors, Reverter, Joan Carles, Carmona, Francisco, Martínez-Zamora, María Ángeles

    “…Objective: Circulating cell-derived microparticles have been reported to be elevated in inflammatory and procoagulant conditions including deep infiltrating…”
    Get full text
    Journal Article
  19. 19

    Thrombin-activatable fibrinolysis inhibitor genetic polymorphisms as markers of the type of acute coronary syndrome by Tàssies, Dolors, Roqué, Merce, Monteagudo, Joan, Martorell, Teresa, Sionis, Alessandro, Arzamendi, Dabit, Heras, Magda, Reverter, Joan-Carles

    Published in Thrombosis research (01-11-2009)
    “…Abstract Introduction In patients with coronary disease at risk of acute coronary events it is unclear which biological factors could predict the type of acute…”
    Get full text
    Journal Article
  20. 20

    Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin by Espinosa, Gerard, Font, Josep, Tàssies, Dolors, Vidaller, Antonio, Deulofeu, Ramon, López-Soto, Alfons, Cervera, Ricard, Ordinas, Antoni, Ingelmo, Miguel, Reverter, Joan-Carles

    Published in The American journal of medicine (01-01-2002)
    “…Thrombosis, usually venous, occurs in 10% to 25% of patients with Behçet's disease, but its pathogenesis is poorly understood. We evaluated parameters of…”
    Get more information
    Journal Article